Prescription of alpha-blockers after TURP: Are we reviewing medications appropriately?
BAUS ePoster online library. Henry M. 06/25/19; 265261; CU-8
Ms. Mei-Ling Henry
Ms. Mei-Ling Henry
Login now to access Regular content available to all registered users.

You may also access this content "anytime, anywhere" with the Free MULTILEARNING App for iOS and Android
Abstract
Rate & Comment (0)
Aims
This audit aimed to ascertain current practice at a single centre for urology, regarding the prescription of alpha-blockers for lower urinary tract symptoms after TURP for benign dis-ease.

Method
Retrospective data were collected for consecutive patients undergoing TURP over an 8 week period at a single centre for urology using electronic discharge summaries and the pa-tient summary care record. National guidelines for management of male LUTS were used to set criteria and standards.

Results
75.8% of patients had a repeat prescription for an alpha-blocker pre-operatively (25/33). 72.0% of these patients still had an alpha blocker on repeat prescription from their GP prac-tice at one month post-operatively (18/25). Of these patients, 33.3% had an alpha-blocker prescription issued from their GP after their discharge from hospital (6/18). 24.0% of patients had an alpha-blocker appropriately discontinued by their GP(6/25). One patient had their al-pha-blocker appropriately discontinued on their discharge summary. Of the remaining pa-tients, 12.5% had advice on their discharge summary regarding discontinuation of alpha-blockers (4/32). 84.8% of discharge summaries written did not contain advice regarding al-pha-blockers (28/33).

Conclusion
This audit demonstrated that a large proportion of patients are inappropriately prescribed an alpha-blocker following a TURP. By continuing repeat prescription of unnecessary alpha-blockers we may be putting patients at increased risk of falls, with morbidity to the patient and financial implication to the health service.


INTRODUCTION
Lower urinary tract symptoms (LUTS) are a common presenting complaint in the ageing male population and an important factor impairing quality of life in men. Significant LUTS oc-cur in up to 30% of men aged over 65 (NICE, 2010) and there is an association between presence of LUTS and increased age (Martin et al).
Current guidance from the National Instit
Aims
This audit aimed to ascertain current practice at a single centre for urology, regarding the prescription of alpha-blockers for lower urinary tract symptoms after TURP for benign dis-ease.

Method
Retrospective data were collected for consecutive patients undergoing TURP over an 8 week period at a single centre for urology using electronic discharge summaries and the pa-tient summary care record. National guidelines for management of male LUTS were used to set criteria and standards.

Results
75.8% of patients had a repeat prescription for an alpha-blocker pre-operatively (25/33). 72.0% of these patients still had an alpha blocker on repeat prescription from their GP prac-tice at one month post-operatively (18/25). Of these patients, 33.3% had an alpha-blocker prescription issued from their GP after their discharge from hospital (6/18). 24.0% of patients had an alpha-blocker appropriately discontinued by their GP(6/25). One patient had their al-pha-blocker appropriately discontinued on their discharge summary. Of the remaining pa-tients, 12.5% had advice on their discharge summary regarding discontinuation of alpha-blockers (4/32). 84.8% of discharge summaries written did not contain advice regarding al-pha-blockers (28/33).

Conclusion
This audit demonstrated that a large proportion of patients are inappropriately prescribed an alpha-blocker following a TURP. By continuing repeat prescription of unnecessary alpha-blockers we may be putting patients at increased risk of falls, with morbidity to the patient and financial implication to the health service.


INTRODUCTION
Lower urinary tract symptoms (LUTS) are a common presenting complaint in the ageing male population and an important factor impairing quality of life in men. Significant LUTS oc-cur in up to 30% of men aged over 65 (NICE, 2010) and there is an association between presence of LUTS and increased age (Martin et al).
Current guidance from the National Instit

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies